Inhaled nitric oxide for acute chest syndrome in adult sickle cell patients: a randomized controlled study

Intensive Care Medicine

Volumn 41, Issue 12, 2015, Pages 2121-2129

  Maitre, B ^a,b,c   Djibre, M ^d,e   Katsahian, S ^a,b   Habibi, A ^a,b   Stankovic Stojanovic, K ^d   Khellaf, M ^a,b   Bourgeon, I ^a,b   Lionnet, F ^d,e   Charles Nelson, A ^a,b   Brochard, L ^a,f   Lemaire, F ^a,b   Galacteros, F ^a,b   Brun Buisson, C ^a,b   Fartoukh, M ^b,d,e   Mekontso Dessap, A ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Acute chest syndrome; Acute lung injury; Anemia; Hemoglobinopathies; Nitric oxide; Sickle cell

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN; METHEMOGLOBIN; NITRIC OXIDE; PLACEBO; ENDOTHELIUM DERIVED RELAXING FACTOR;

ACUTE CHEST SYNDROME; ADULT; ARTICLE; BLOOD TRANSFUSION; CANCER PATIENT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENDOTRACHEAL INTUBATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; INHALER; INOVENT SYSTEM; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OXYGEN SATURATION; PHASE 2 CLINICAL TRIAL; PHLEBOTOMY; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL; SICKLE CELL ANEMIA; SUFFOCATION; TREATMENT FAILURE; XEROSTOMIA; COMPLICATION; INHALATIONAL DRUG ADMINISTRATION; YOUNG ADULT;

ACUTE CHEST SYNDROME; ADMINISTRATION, INHALATION; ADULT; ANEMIA, SICKLE CELL; DOUBLE-BLIND METHOD; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; FEMALE; HUMANS; MALE; NITRIC OXIDE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84946481778     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-4060-2     Document Type: Article

References (25)

1. Vichinsky EP, Styles LA, Colangelo LH et al (1997) Acute chest syndrome in sickle cell disease: clinical presentation and course. cooperative study of sickle cell disease. Blood 89:1787–1792
2. Cecchini J, Lionnet F, Djibré M et al (2014) Outcomes of adult patients with sickle cell disease admitted to the ICU: a case series. Crit Care Med 42:1629–1639. doi:10.1097/CCM.0000000000000316
3. Griffiths MJD, Evans TW (2005) Inhaled nitric oxide therapy in adults. N Engl J Med 353:2683–2695. doi:10.1056/NEJMra051884
4. Morris CR, Kuypers FA, Larkin S et al (2000) Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J Pediatr Hematol Oncol 22:515–520
5. Sullivan KJ, Goodwin SR, Evangelist J et al (1999) Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med 27:2563–2568
6. Martinez-Ruiz R, Montero-Huerta P, Hromi J, Head CA (2001) Inhaled nitric oxide improves survival rates during hypoxia in a sickle cell (SAD) mouse model. Anesthesiology 94:1113–1118
7. De Franceschi L, Baron A, Scarpa A et al (2003) Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation. Blood 102:1087–1096. doi:10.1182/blood-2002-07-2135
8. Germann P, Braschi A, Della Rocca G et al (2005) Inhaled nitric oxide therapy in adults: European expert recommendations. Intensive Care Med 31:1029–1041. doi:10.1007/s00134-005-2675-4
9. Afshari A, Brok J, Møller AM, Wetterslev J (2010) Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database Syst Rev. doi:10.1002/14651858.CD002787.pub2
10. Taylor RW, Zimmerman JL, Dellinger RP et al (2004) Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 291:1603–1609. doi:10.1001/jama.291.13.1603
11. Atz AM, Wessel DL (1997) Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology 87:988–990
12. Oppert M, Jörres A, Barckow D et al (2004) Inhaled nitric oxide for ARDS due to sickle cell disease. Swiss Med Wkly 134:165–167. doi:2004/11/smw-10521
13. Head CA, Swerdlow P, McDade WA et al (2010) Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis. Am J Hematol 85:800–802. doi:10.1002/ajh.21832
14. Gladwin MT, Schechter AN, Shelhamer JH et al (1999) Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity. J Clin Invest 104:937–945. doi:10.1172/JCI7637
15. Weiner DL, Hibberd PL, Betit P et al (2003) Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA 289:1136–1142
16. Gladwin MT, Kato GJ, Weiner D et al (2011) Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA 305:893–902. doi:10.1001/jama.2011.235
17. Fartoukh M, Lefort Y, Habibi A et al (2010) Early intermittent noninvasive ventilation for acute chest syndrome in adults with sickle cell disease: a pilot study. Intensive Care Med 36:1355–1362. doi:10.1007/s00134-010-1907-4
18. The R Foundation for Statistical Computing (2002) R software. Vienna, Austria
19. Reiter CD, Wang X, Tanus-Santos JE et al (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8:1383–1389. doi:10.1038/nm799
20. Gladwin MT, Vichinsky E (2008) Pulmonary complications of sickle cell disease. N Engl J Med 359:2254–2265. doi:10.1056/NEJMra0804411
21. Bernini JC, Rogers ZR, Sandler ES et al (1998) Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 92:3082–3089
22. Mekontso Dessap A, Leon R, Habibi A et al (2008) Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 177:646–653. doi:10.1164/rccm.200710-1606OC
23. Mekontso Dessap A, Deux J-F, Abidi N et al (2011) Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 184:1022–1029. doi:10.1164/rccm.201105-0783OC
24. Hess JR, MacDonald VW, Brinkley WW (1993) Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1985(74):1769–1778
25. Lee R, Neya K, Svizzero TA, Vlahakes GJ (1995) Limitations of the efficacy of hemoglobin-based to oxygen-carrying solutions. J Appl Physiol 1985(79):236–242